Andrew Cheng, President and CEO: Akero Therapeutics AKRO Sell · Filed 24/06/13

Trade details

Type: Insider sale
Amount: $178,720.16
Shares · price: 7,894 sh · $22.64 a share
Held after: 581,553 sh
Stock: Akero Therapeutics AKRO
Person: Andrew ChengPresident and CEO
Trade date: 24/06/11
Filed: 24/06/13
Days to filing: 2 days

Sold 1.3% of holdings

Share of holding sold: 1.3%

Akero Therapeutics trades, last 26 weeks

What else happened in Akero Therapeutics around then

Filed or reported within 30 days of the trade day · 24/05/12~24/07/11

Andrew Cheng's recent trades

Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$1.6M
30,000 sh
$1.6M
Filed 25/10/14
Traded 25/10/10
Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$968.3K
22,525 sh
$968.3K
Filed 25/09/12
Traded 25/09/10
Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$321.9K
7,317 sh
$321.9K
Filed 25/09/12
Traded 25/09/10
Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$77.3K
1,796 sh
$77.3K
Filed 25/09/12
Traded 25/09/11
Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$7,050
158 sh
$7,050
Filed 25/09/12
Traded 25/09/10